pLVX-EF1alpha-eGFP-2xStrep-IRES-Puro Citations (13)

Originally described in: A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O'Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, Huttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Meyer B, Roesch F, Vallet T, Mac Kain A, Miorin L, Moreno E, Naing ZZC, Zhou Y, Peng S, Shi Y, Zhang Z, Shen W, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Lyu J, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Rakesh R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Huang XP, Liu Y, Wankowicz SA, Bohn M, Safari M, Ugur FS, Koh C, Savar NS, Tran QD, Shengjuler D, Fletcher SJ, O'Neal MC, Cai Y, Chang JCJ, Broadhurst DJ, Klippsten S, Sharp PP, Wenzell NA, Kuzuoglu-Ozturk D, Wang HY, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Stroud RM, Frankel AD, Rosenberg OS, Verba KA, Agard DA, Ott M, Emerman M, Jura N, von Zastrow M, Verdin E, Ashworth A, Schwartz O, d'Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor SN, Fraser JS, Gross JD, Sali A, Roth BL, Ruggero D, Taunton J, Kortemme T, Beltrao P, Vignuzzi M, Garcia-Sastre A, Shokat KM, Shoichet BK, Krogan NJ Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30. PubMed Journal

---

Articles Citing pLVX-EF1alpha-eGFP-2xStrep-IRES-Puro

Articles
SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. Vazquez C, Swanson SE, Negatu SG, Dittmar M, Miller J, Ramage HR, Cherry S, Jurado KA. PLoS One. 2021 Jun 24;16(6):e0253089. doi: 10.1371/journal.pone.0253089. eCollection 2021. PubMed
Effect of SARS-CoV-2 proteins on vascular permeability. Rauti R, Shahoha M, Leichtmann-Bardoogo Y, Nasser R, Paz E, Tamir R, Miller V, Babich T, Shaked K, Ehrlich A, Ioannidis K, Nahmias Y, Sharan R, Ashery U, Maoz BM. Elife. 2021 Oct 25;10. pii: 69314. doi: 10.7554/eLife.69314. PubMed
Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive Immunity. Lopez-Munoz AD, Kosik I, Holly J, Yewdell JW. bioRxiv. 2021 Dec 13. doi: 10.1101/2021.12.10.472169. PubMed
Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral gene Orf9c on human pluripotent stem cell-derived cardiomyocytes. Liu J, Zhang Y, Han L, Guo S, Wu S, Doud EH, Wang C, Chen H, Rubart-von der Lohe M, Wan J, Yang L. Stem Cell Reports. 2022 Mar 8;17(3):522-537. doi: 10.1016/j.stemcr.2022.01.014. Epub 2022 Feb 17. PubMed
SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome. Zaffagni M, Harris JM, Patop IL, Pamudurti NR, Nguyen S, Kadener S. Elife. 2022 Mar 16;11. pii: 71945. doi: 10.7554/eLife.71945. PubMed
Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity. Lopez-Munoz AD, Kosik I, Holly J, Yewdell JW. Sci Adv. 2022 Aug 5;8(31):eabp9770. doi: 10.1126/sciadv.abp9770. Epub 2022 Aug 3. PubMed
A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. Zhou Y, Liu Y, Gupta S, Paramo MI, Hou Y, Mao C, Luo Y, Judd J, Wierbowski S, Bertolotti M, Nerkar M, Jehi L, Drayman N, Nicolaescu V, Gula H, Tay S, Randall G, Wang P, Lis JT, Feschotte C, Erzurum SC, Cheng F, Yu H. Nat Biotechnol. 2023 Jan;41(1):128-139. doi: 10.1038/s41587-022-01474-0. Epub 2022 Oct 10. PubMed
SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D. Lee MJ, Leong MW, Rustagi A, Beck A, Zeng L, Holmes S, Qi LS, Blish CA. Cell Rep. 2022 Dec 27;41(13):111892. doi: 10.1016/j.celrep.2022.111892. Epub 2022 Dec 12. PubMed
Fragile X-Related Protein FXR1 Controls Human Adenovirus Capsid mRNA Metabolism. Hajikhezri Z, Kaira Y, Schubert E, Darweesh M, Svensson C, Akusjarvi G, Punga T. J Virol. 2023 Feb 28;97(2):e0153922. doi: 10.1128/jvi.01539-22. Epub 2023 Feb 7. PubMed
Cell Surface Nucleocapsid Protein Expression: A Betacoronavirus Immunomodulatory Strategy. Lopez-Munoz AD, Santos JJS, Yewdell JW. bioRxiv [Preprint]. 2023 Feb 27:2023.02.24.529952. doi: 10.1101/2023.02.24.529952. PubMed
Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor. Lainscek D, Golob-Urbanc A, Mikolic V, Pantovic-Zalig J, Malensek S, Jerala R. Mol Ther Oncolytics. 2023 Apr 26;29:77-90. doi: 10.1016/j.omto.2023.04.005. eCollection 2023 Jun 15. PubMed
SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells. Kim IJ, Lee YH, Khalid MM, Chen IP, Zhang Y, Ott M, Verdin E. J Biol Chem. 2023 Aug;299(8):104955. doi: 10.1016/j.jbc.2023.104955. Epub 2023 Jun 23. PubMed
Toll-like receptor 4 signaling activation domains promote CAR T cell function against solid tumors. Mikolic V, Pantovic-Zalig J, Malensek S, Sever M, Lainscek D, Jerala R. Mol Ther Oncol. 2024 May 14;32(2):200815. doi: 10.1016/j.omton.2024.200815. eCollection 2024 Jun 20. PubMed

If you have published an article using this material, please email us at to have your article added to this page.